Ping Ren Selected Research

chaihu-shugan-san

7/2019	Chaihu-Shugan-San and absorbed meranzin hydrate induce anti-atherosclerosis and behavioral improvements in high-fat diet ApoE-/- mice via anti-inflammatory and BDNF-TrkB pathway.
9/2011	Pharmacokinetic study of the prokinetic compounds meranzin hydrate and ferulic acid following oral administration of Chaihu-Shugan-San to patients with functional dyspepsia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ping Ren Research Topics

Disease

19	Neoplasms (Cancer) 08/2022 - 05/2012
9	Infections 12/2022 - 04/2005
9	Inflammation (Inflammations) 01/2021 - 01/2015
7	COVID-19 06/2022 - 01/2020
5	Dyspepsia (Indigestion) 06/2019 - 05/2006
5	Myocardial Infarction 01/2017 - 12/2008
5	Infarction (Infarctions) 01/2011 - 10/2007
4	Neoplasm Metastasis (Metastasis) 07/2021 - 01/2018
4	Adenocarcinoma of Lung 06/2021 - 01/2014
4	Lung Neoplasms (Lung Cancer) 01/2020 - 03/2015
3	Atherosclerotic Plaque (Atheroma) 01/2022 - 07/2019
3	Asthma (Bronchial Asthma) 08/2021 - 04/2002
3	Wounds and Injuries (Trauma) 01/2021 - 05/2008
3	Cognitive Dysfunction 01/2019 - 01/2017
3	Acidosis 01/2018 - 12/2015
3	Myocardial Ischemia (Ischemic Heart Diseases) 02/2010 - 10/2007
2	Cardiomegaly (Heart Hypertrophy) 03/2022 - 01/2022
2	Anorexia 02/2022 - 01/2020
2	Breakthrough Infections 01/2022 - 12/2021
2	Sudden Infant Death (SID) 11/2021 - 08/2011
2	Sepsis (Septicemia) 01/2020 - 01/2020
2	Atherosclerosis 12/2019 - 07/2019
2	Zika Virus Infection 10/2017 - 03/2017
2	Ischemia 01/2017 - 05/2009
2	Neuroblastoma 12/2015 - 01/2015
2	Coronary Disease (Coronary Heart Disease) 02/2010 - 10/2007
2	Hypoxia (Hypoxemia) 08/2008 - 05/2008
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2022
1	Phototoxic Dermatitis (Phototoxicity) 05/2022
1	Panic Disorder (Panic Attack) 01/2022
1	Endocarditis 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2008
7	VaccinesIBA 12/2022 - 03/2017
6	ferulic acid (sodium ferulate)IBA 01/2022 - 05/2006
6	Neutralizing AntibodiesIBA 01/2022 - 10/2017
5	Long Noncoding RNAIBA 03/2022 - 12/2019
5	Caspase 3 (Caspase-3)IBA 01/2022 - 10/2007
5	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2014
4	Oxygen (Dioxygen)IBA 11/2021 - 01/2008
4	CytokinesIBA 08/2021 - 01/2010
4	RNA (Ribonucleic Acid)IBA 07/2021 - 04/2005
4	meranzin hydrateIBA 01/2021 - 09/2011
3	Pharmaceutical PreparationsIBA 07/2022 - 01/2020
3	Viral RNAIBA 06/2022 - 04/2006
3	AntigensIBA 06/2022 - 01/2020
3	Glutamine (L-Glutamine)FDA Link 01/2022 - 01/2015
3	Antiviral Agents (Antivirals)IBA 01/2022 - 06/2020
3	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 01/2020
3	MicroRNAs (MicroRNA)IBA 08/2021 - 01/2020
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2010
3	Monoclonal AntibodiesIBA 01/2021 - 01/2014
3	Apolipoproteins E (ApoE)IBA 12/2019 - 01/2017
3	Acid Sensing Ion ChannelsIBA 01/2018 - 12/2015
3	EnzymesIBA 10/2017 - 01/2011
3	guan xin IIIBA 01/2010 - 10/2007
2	Chimeric Antigen ReceptorsIBA 08/2022 - 03/2021
2	Polysaccharides (Glycans)IBA 07/2022 - 01/2021
2	Small Interfering RNA (siRNA)IBA 03/2022 - 03/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 11/2021
2	Biological ProductsIBA 01/2022 - 01/2016
2	Lysine (L-Lysine)FDA Link 11/2021 - 08/2011
2	AntibodiesIBA 01/2021 - 10/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2010
2	hydroxysafflor yellow AIBA 01/2021 - 01/2011
2	NF-kappa B (NF-kB)IBA 01/2021 - 01/2010
2	Messenger RNA (mRNA)IBA 10/2020 - 07/2019
2	peoniflorinIBA 01/2020 - 01/2011
2	shigyaku-san (Si-Ni-San)IBA 01/2020 - 06/2019
2	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2020 - 01/2020
2	Sucrose (Saccharose)IBA 12/2019 - 07/2019
2	LipidsIBA 12/2019 - 07/2019
2	chaihu-shugan-sanIBA 07/2019 - 09/2011
2	Uric Acid (Urate)IBA 05/2018 - 09/2017
2	Estrogens (Estrogen)FDA Link 01/2018 - 10/2011
2	Neuroprotective AgentsIBA 01/2016 - 10/2011
2	AutoantibodiesIBA 06/2015 - 10/2010
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2013 - 12/2008
2	xiaoyaoIBA 08/2009 - 05/2006
2	AllergensIBA 08/2003 - 04/2002
1	BNT162 VaccineIBA 12/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 12/2022
1	MXeneIBA 06/2022
1	SiliconIBA 05/2022
1	trimethoxysilaneIBA 05/2022
1	Silicon Dioxide (Silica)FDA LinkGeneric 03/2022
1	xiaoyaosanIBA 02/2022
1	Docosahexaenoic AcidsIBA 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Alanine (L-Alanine)FDA Link 01/2022
1	NucleolinIBA 01/2022
1	PhosphoproteinsIBA 01/2022
1	Cysteine (L-Cysteine)FDA Link 01/2022

Therapy/Procedure

10	Therapeutics 08/2022 - 02/2010
5	Oral Administration 06/2019 - 01/2009
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2017 - 09/2011
1	Transjugular Intrahepatic Portasystemic Shunt 01/2022